Figure 3From: Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B Clinical courses of 5 HCC patients from entry to the study to development of HCC. The changes of ALT level (gray lines) and HBV-DNA level (black line) were depicted. Arrow, time-point of HCC diagnosis; Solid bar, duration of LAM used; Shaded bar, duration of ETV used; Empty bar, duration of ADV used.Back to article page